BRPI0418301A - pharmaceutically acceptable compound or salt, method for preparing compound, pharmaceutical composition and therapeutic agent - Google Patents
pharmaceutically acceptable compound or salt, method for preparing compound, pharmaceutical composition and therapeutic agentInfo
- Publication number
- BRPI0418301A BRPI0418301A BRPI0418301-0A BRPI0418301A BRPI0418301A BR PI0418301 A BRPI0418301 A BR PI0418301A BR PI0418301 A BRPI0418301 A BR PI0418301A BR PI0418301 A BRPI0418301 A BR PI0418301A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- compound
- salt
- pharmaceutically acceptable
- therapeutic agent
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
COMPOSTO OU SAL FARMACEUTICAMENTE ACEITáVEL, MéTODO PARA PREPARAR COMPOSTO, COMPOSIçãO FARMACêUTICA E AGENTE TERAPêUTICO Esta invenção refere-se a novos derivados de piridina tendo um efeito inibidor na produção de citocinas, os quais são envolvidos na resposta inflamatória, assim sugerindo suas desvantagens como agentes terapêuticos para tratamento de doenças relacionadas à inflamaçao, sistema imune, inflamação crónica bem como um agente tendo um efeito analgésico e inflamatório. além disso, esta invenção refere-se a um método de fabricar o mesmo e uma composição farmacêutica contendo o mesmo.PHARMACEUTICALLY ACCEPTABLE COMPOUND OR SALT, METHOD FOR PREPARING COMPOUND, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC AGENT This invention relates to novel pyridine derivatives having an inhibitory effect on cytokines, which are involved in the inflammatory response, thus suggesting their disadvantages as therapeutic agents. for treating diseases related to inflammation, the immune system, chronic inflammation as well as an agent having an analgesic and inflammatory effect. furthermore, this invention relates to a method of manufacturing the same and a pharmaceutical composition containing the same.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20031000132 | 2003-12-30 | ||
PCT/KR2004/003545 WO2005063768A1 (en) | 2003-12-30 | 2004-12-30 | Novel pyridine derivatives, a process for their preparation and a pharmaceutical composition containing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0418301A true BRPI0418301A (en) | 2007-05-02 |
Family
ID=38007660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0418301-0A BRPI0418301A (en) | 2003-12-30 | 2004-12-30 | pharmaceutically acceptable compound or salt, method for preparing compound, pharmaceutical composition and therapeutic agent |
Country Status (1)
Country | Link |
---|---|
BR (1) | BRPI0418301A (en) |
-
2004
- 2004-12-30 BR BRPI0418301-0A patent/BRPI0418301A/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2016031I1 (en) | TOPICAL PHARMACEUTICAL FORM OF IVERMECTIN FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS | |
ECSP055669A (en) | DERIVATIVES OF PYRIMIDINONE AS THERAPEUTIC AGENTS AGAINST REMODELING, ISCHEMICAL AND INFLAMMATORY PROCESSES, ACUTE AND CHRONIC | |
ECSP056194A (en) | DERIVATIVES OF PIRAZOLO-QUINAZOLINA, PROCEDURE FOR ITS PREPARATION AND ITS USE AS QUINASA INHIBITORS | |
ATE411022T1 (en) | PYRIDYLPYRROLE DERIVATIVES AS EFFECTIVE KINASE INHIBITORS | |
ECSP088869A (en) | DERIVATIVES OF 2-PIRAZINONE FOR THE TREATMENT OF DISEASES OR CONDITIONS WHERE THE INHIBITION OF THE ACTIVITY OF NEUTROPHYLICAL ELASTASA IS BENEFICIAL | |
CR20110608A (en) | DERIVATIVES OF 1H-IMIDAZO- [4,5-C] -QUINOLINONA | |
CL2004001011A1 (en) | AZABICICLIC COMPOUNDS DERIVED FROM N-ARILSULFONILPIPERIDINAS; INHIBITORS OF THE DEPOSITION OF PROTEIN BETA AMYLOID; PHARMACEUTICAL COMPOSITION; AND ITS USE FOR THE TREATMENT OF ALZHEIMER AND NEURODEGENERATIVE DISEASES. | |
DE602004019206D1 (en) | ANTI-INFLAMMATORY MEDICINE PREPARATIONS FOR INFLAMMATORY INFLAMMATION AND THE THERAPY OR PROPHYLAXIS OF GASTRIC TOXICITY | |
ECSP21051825A (en) | COMPOUNDS AND THEIR USE FOR THE TREATMENT OF α1-ANTITRYPSIN DEFICIENCY | |
ATE448232T1 (en) | SUBSTITUTED HETEROCYCLES | |
MX2020003993A (en) | Benzimidazole derivatives and their uses. | |
EA200801580A1 (en) | NEW PIRININOD DERIVATIVES AND METHOD FOR THEIR PRODUCTION | |
BR0312722A (en) | Heterobicylic pyrazole derivatives as kinase inhibitors | |
BR0314797A (en) | Pyrimidineamide derivatives and their use | |
ATE287267T1 (en) | COMBINATION THERAPIES WITH VASCULAR DAMAGE ACTIVITY | |
ATE396986T1 (en) | PYRIMIDYLPYRROLE DERIVATIVES THAT ACTION AS KINASE INHIBITORS | |
BR0313718A (en) | Compound, process for the preparation thereof, pharmaceutical composition, methods for treating a human or animal subject suffering from a condition which is cox-2 mediated and for treating a human or animal subject suffering from an inflammatory disorder, and, use of a compound | |
NO20043792L (en) | New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine | |
CO2020016480A2 (en) | Topical salts of amlodipine for the treatment of anorectal diseases | |
NO20044498L (en) | Combination therapy for the treatment of cancer | |
ATE413187T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING INTERFERON TAU | |
SV2006002192A (en) | AMIDAS OF ACID 5 AND 6-AMINOALQUIL INDOL-2-CARBOXILICO 3-SUBSTITUTES AND RELATED ANALOGS AS INHIBITORS OF CASEINA CINASA IE | |
BRPI0418301A (en) | pharmaceutically acceptable compound or salt, method for preparing compound, pharmaceutical composition and therapeutic agent | |
WO2018067638A3 (en) | High mobility group b1 protein inhibitors | |
UY26945A1 (en) | PHENOXYPHENYL ALCANOSULPHONATES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |